|
1
|
Takagi S, Tsuji T, Amagai T, Takamatsu T
and Fujisawa H: Specific cell surface labels in the visual centers
of Xenopus laevis tadpole identified using monoclonal antibodies.
Dev Biol. 122:90–100. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Raimondi C and Ruhrberg C: Neuropilin
signalling in vessels, neurons and tumours. Semin Cell Dev Biol.
24:172–178. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Prud'homme GJ and Glinka Y: Neuropilins
are multifunctional coreceptors involved in tumor initiation,
growth, metastasis and immunity. Oncotarget. 3:921–939. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Geretti E, Shimizu A and Klagsbrun M:
Neuropilin structure governs VEGF and semaphorin binding and
regulates angiogenesis. Angiogenesis. 11:31–39. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Geretti E and Klagsbrun M: Neuropilins:
Novel targets for antiangiogenesis therapies. Cell Adhes Migr.
1:56–61. 2007. View Article : Google Scholar
|
|
6
|
Chaudhary B, Khaled YS, Ammori BJ and
Elkord E: Neuropilin 1: Function and therapeutic potential in
cancer. Cancer Immunol Immunother. 63:81–99. 2014. View Article : Google Scholar
|
|
7
|
Plein A, Fantin A and Ruhrberg C:
Neuropilin regulation of angiogenesis, arteriogenesis, and vascular
permeability. Microcirculation. 21:315–323. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sulpice E, Plouët J, Bergé M, Allanic D,
Tobelem G and Merkulova-Rainon T: Neuropilin-1 and neuropilin-2 act
as coreceptors, potentiating proangiogenic activity. Blood.
111:2036–2045. 2008. View Article : Google Scholar
|
|
9
|
Parker MW, Xu P, Li X and Vander Kooi CW:
Structural basis for selective vascular endothelial growth factor-A
(VEGF-A) binding toneuropilin-1. J Biol Chem. 287:11082–11089.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kärpänen T, Heckman CA, Keskitalo S,
Jeltsch M, Ollila H, Neufeld G, Tamagnone L and Alitalo K:
Functional interaction of VEGF-C and VEGF-D with neuropilin
receptors. FASEB J. 20:1462–1472. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yuan L, Moyon D, Pardanaud L, Bréant C,
Karkkainen MJ, Alitalo K and Eichmann A: Abnormal lymphatic vessel
development in neuropilin 2 mutant mice. Development.
129:4797–4806. 2002.PubMed/NCBI
|
|
12
|
Zhang Y, Liu P, Jiang Y, Dou X, Yan J, Ma
C, Fan Q, Wang W, Su F, Tang H, et al: High expression of
neuropilin-1 associates with unfavorable clinicopathological
features in hepatocellular carcinoma. Pathol Oncol Res. 22:367–375.
2016. View Article : Google Scholar
|
|
13
|
Hey-Cunningham AJ, Markham R, Fraser IS
and Berbic M: Dysregulation of vascular endothelial growth factors
and their neuropilin receptors in the eutopic endometrium of women
with endometriosis. Reprod Sci. 20:1382–1389. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Samuel S, Gaur P, Fan F, Xia L, Gray MJ,
Dallas NA, Bose D, Rodriguez-Aguayo C, Lopez-Berestein G, Plowman
G, et al: Neuropilin-2 mediated β-catenin signaling and survival in
human gastro-intestinal cancer cell lines. PLoS One. 6:e232082011.
View Article : Google Scholar
|
|
15
|
Nasarre P, Gemmill RM, Potiron VA, Roche
J, Lu X, Barón AE, Korch C, Garrett-Mayer E, Lagana A, Howe PH, et
al: Neuropilin-2 Is upregulated in lung cancer cells during
TGF-β1-induced epithelial-mesenchymal transition. Cancer Res.
73:7111–7121. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cao Y, Hoeppner LH, Bach S, E G, Guo Y,
Wang E, Wu J, Cowley MJ, Chang DK, Waddell N, et al: Neuropilin-2
promotes extravasation and metastasis by interacting with
endothelial α5 integrin. Cancer Res. 73:4579–4590. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dallas NA, Gray MJ, Xia L, Fan F, van
Buren G II, Gaur P, Samuel S, Lim SJ, Arumugam T, Ramachandran V,
et al: Neuropilin-2-mediated tumor growth and angiogenesis in
pancreatic adenocarcinoma. Clin Cancer Res. 14:8052–8060. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dutta S, Roy S, Polavaram NS, Baretton GB,
Muders MH, Batra S and Datta K: NRP2 transcriptionally regulates
its downstream effector WDFY1. Sci Rep. 6:235882016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gray MJ, Van Buren G, Dallas NA, Xia L,
Wang X, Yang AD, Somcio RJ, Lin YG, Lim S, Fan F, et al:
Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells
implanted in the murine liver. J Natl Cancer Inst. 100:109–120.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dutta S, Roy S, Polavaram NS, Stanton MJ,
Zhang H, Bhola T, Hönscheid P, Donohue TM Jr, Band H, Batra SK, et
al: Neuropilin-2 regulates endosome maturation and EGFR trafficking
to support cancer cell pathobiology. Cancer Res. 76:418–428. 2016.
View Article : Google Scholar :
|
|
21
|
Keck B, Wach S, Taubert H, Zeiler S, Ott
OJ, Kunath F, Hartmann A, Bertz S, Weiss C, Hönscheid P, et al:
Neuropilin-2 and its ligand VEGF-C predict treatment response after
transurethral resection and radiochemotherapy in bladder cancer
patients. Int J Cancer. 136:443–451. 2015. View Article : Google Scholar
|
|
22
|
Caunt M, Mak J, Liang WC, Stawicki S, Pan
Q, Tong RK, Kowalski J, Ho C, Reslan HB, Ross J, et al: Blocking
neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell.
13:331–342. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun H, England CG, Hernandez R, Graves SA,
Majewski RL, Kamkaew A, Jiang D, Barnhart TE, Yang Y and Cai W:
ImmunoPET for assessing the differential uptake of a CD146-specific
monoclonal antibody in lung cancer. Eur J Nucl Med Mol Imaging.
43:2169–2179. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang Y, Chen N, Li Z, Wang XJ, Wang SY,
Tingwu, Luo FH and Yan JH: Preparation, purification, and
identification of a monoclonal antibody against NRP2 b1b2 domain.
Monoclon Antib Immunodiagn Immunother. 34:354–359. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Su X, Chen Q, Chen W, Chen T, Li W, Li Y,
Dou X, Zhang Y, Shen Y, Wu H, et al: Mycoepoxydiene inhibits
activation of BV2 microglia stimulated by lipopolysaccharide
through suppressing NF-κB, ERK 1/2 and toll-like receptor pathways.
Int Immunopharmacol. 19:88–93. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dou X, Yan J, Zhang Y, Liu P, Jiang Y, Lv
S, Zeng F, Chen X, Wang S, Zhang H, et al: SPECT imaging of
neuropilin receptor type-1 expression with 131I-labeled
monoclonal antibody. Int J Oncol. 49:961–970. 2016.PubMed/NCBI
|
|
27
|
Guo Z, Gao M, Zhang D, Li Y, Song M,
Zhuang R, Su X, Chen G, Liu T, Liu P, et al: Simultaneous SPECT
imaging of multi-targets to assist in identifying hepatic lesions.
Sci Rep. 6:288122016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Su X, Cheng K, Liu Y, Hu X, Meng S and
Cheng Z: PET imaging of insulin-like growth factor type 1 receptor
expression with a 64Cu-labeled Affibody molecule. Amino Acids.
47:1409–1419. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Su X, Cheng K, Jeon J, Shen B, Venturin
GT, Hu X, Rao J, Chin FT, Wu H and Cheng Z: Comparison of two
site-specifically (18)F-labeled affibodies for PET imaging of EGFR
positive tumors. Mol Pharm. 11:3947–3956. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guo Z, Gao M, Song M, Shi C, Zhang P, Xu
D, You L, Zhuang R, Su X, Liu T, et al: Synthesis and evaluation of
(99m)Tc-labeled dimeric folic acid for FR-targeting. Molecules.
21:E8172016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen H, Chédotal A, He Z, Goodman CS and
Tessier-Lavigne M: Neuropilin-2, a novel member of the neuropilin
family, is a high affinity receptor for the semaphorins Sema E and
Sema IV but not Sema III. Neuron. 19:547–559. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stanton MJ, Dutta S, Zhang H, Polavaram
NS, Leontovich AA, Hönscheid P, Sinicrope FA, Tindall DJ, Muders MH
and Datta K: Autophagy control by the VEGF-C/NRP-2 axis in cancer
and its implication for treatment resistance. Cancer Res.
73:160–171. 2013. View Article : Google Scholar :
|
|
33
|
Parker MW and Vander Kooi CW:
Microplate-based screening for small molecule inhibitors of
neuropilin-2/vascular endothelial growth factor-C interactions.
Anal Biochem. 453:4–6. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jubb AM, Sa SM, Ratti N, Strickland LA,
Schmidt M, Callahan CA and Koeppen H: Neuropilin-2 expression in
cancer. Histopathology. 61:340–349. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tomizawa Y, Sekido Y, Kondo M, Gao B,
Yokota J, Roche J, Drabkin H, Lerman MI, Gazdar AF and Minna JD:
Inhibition of lung cancer cell growth and induction of apoptosis
after reexpression of 3p21.3 candidate tumor suppressor gene
SEMA3B. Proc Natl Acad Sci USA. 98:13954–13959. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Khan AH and Sadroddiny E: Licensed
monoclonal antibodies and associated challenges. Hum Antibodies.
23:63–72. 2015. View Article : Google Scholar
|
|
37
|
Aung NY, Ohe R, Meng H, Kabasawa T, Yang
S, Kato T and Yamakawa M: Specific neuropilins expression in
alveolar macrophages among tissue-specific macrophages. PLoS One.
11:e01473582016. View Article : Google Scholar : PubMed/NCBI
|
